XML 85 R65.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Revenues (Details Textual) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2019 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Dec. 31, 2018 | Sep. 30, 2018 | Jun. 30, 2018 | Mar. 31, 2018 | Dec. 31, 2019 | Dec. 31, 2018 | Dec. 31, 2017
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Revenues | $ 3,671.3 | $ 3,600.1 | $ 3,616.7 | $ 3,489.8 | $ 3,526.3 | $ 3,439.0 | $ 3,356.5 | $ 3,131.1 | $ 14,377.9 | $ 13,452.9 | $ 12,273.9
Revenues In Percentage From Anti-CD20 Therapeutic Programs |  |  |  |  |  |  |  |  | 16.00% | 15.00% | 13.00%
Distributor One |  |  |  |  |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Percentage of revenue from major distributors |  |  |  |  |  |  |  |  | 30.00% | 32.00% | 34.00%
Percentage receivables of wholesale distributor accounted in consolidated receivables | 24.10% |  |  |  | 27.70% |  |  |  | 24.10% | 27.70% |
Distributor Two |  |  |  |  |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Percentage of revenue from major distributors |  |  |  |  |  |  |  |  | 17.00% | 18.00% | 21.00%
Percentage receivables of wholesale distributor accounted in consolidated receivables | 13.90% |  |  |  | 15.60% |  |  |  | 13.90% | 15.60% |
Other revenue |  |  |  |  |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Revenues | $ 145.7 | $ 109.6 | $ 160.0 | $ 292.4 | $ 165.7 | $ 147.2 | $ 108.6 | $ 164.4 | $ 707.7 | $ 585.9 | $ 360.0
Other revenue | Bioverativ |  |  |  |  |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  | 383.2 | 206.7 | 64.8
Other corporate revenues |  |  |  |  |  |  |  |  |  |  |
Disaggregation of Revenue [Line Items] |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  | 584.5 | $ 459.4 | $ 253.7
Revenue, Remaining Performance Obligation, Amount | $ 500.0 |  |  |  |  |  |  |  | $ 500.0 |  |

X
- Definition Entity wide percentage of revenue from major distributors. + References No definition available. + Details
Name: | biib_EntityWidePercentageOfRevenueFromMajorDistributors
Namespace Prefix: | biib_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage receivables of wholesale distributor accounted in consolidated receivables. + References No definition available. + Details
Name: | biib_PercentageReceivablesOfWholesaleDistributorAccountedInConsolidatedReceivables
Namespace Prefix: | biib_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Revenues In Percentage From Anti-CD20 Therapeutic Programs + References No definition available. + Details
Name: | biib_RevenuesInPercentageFromAntiCD20TherapeuticPrograms
Namespace Prefix: | biib_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 13 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130556-203045 + Details
Name: | us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(1)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 + Details
Name: | us-gaap_Revenues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | biib_MajorDistributorAxis=biib_DistributorOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | biib_MajorDistributorAxis=biib_DistributorTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_MajorCustomersAxis=biib_BioverativMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=biib_OthercorporaterevenuesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |